With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
Zacks Investment Research on MSN21h
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
In a report released on March 14, Akash Tewari from Jefferies maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report), with a ...
We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...
DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the ...
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Jeff Lilly has been named director of technology for Nexstar’s Chicago owned station WGN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback